# ::id 1
# ::snt A single round of treatment with an experimental
(x3 / round
	:mod (x2 / single)
	:mod (x5 / treat-03
		:manner (x8 / experiment-01)))

# ::id 2
# ::snt new medicine appears to be highly effective against a rare form of
(x3 / appear-02
	:ARG1 (x2 / medicine
		:mod (x1 / new))
	:ARG1 (x7 / effective
		:degree (x6 / high)
		:prep-against (x11 / form
			:mod (x10 / rare))))

# ::id 3
# ::snt leukemia and may help fight other kinds of blood cancer as well,
(x1 / disease
	:name (n / name
		:op1 "leukemia")
	:domain (x4 / help-01
		:ARG1 (x2 / and)
		:mod (x3 / possible)
		:ARG1 (x5 / fight-01
			:ARG0 x2
			:ARG1 (x10 / cancer
				:mod (x7 / kind
					:mod (x6 / other))
				:mod (x9 / blood)))))

# ::id 4
# ::snt says a study published today.
(x1 / say-01
	:ARG0 (x3 / study
		:ARG1-of (x4 / publish-01
			:time (x5 / today))))

# ::id 5
# ::snt The new drug was developed at Scripps Clinic and Research
(x5 / develop-02
	:ARG1 (x3 / drug
		:mod (x2 / new))
	:location (x7 / government-organization
		:name (n / name
			:op1 "Scripps"
			:op2 "Clinic"
			:op3 "and"
			:op4 "Research")))

# ::id 6
# ::snt Foundation in La Jolla, Calif., where doctors tested it on patients
(x1 / foundation
	:location (x4 / country
		:name (n / name
			:op1 "Jolla")
		:null_edge (x3 / country
			:name (n1 / name
				:op1 "La"))
		:null_edge (x6 / country
			:name (n2 / name
				:op1 "Calif.")))
	:ARG1-of (x10 / test-01
		:ARG0 (x9 / doctor)
		:ARG2 (x13 / patient)))

# ::id 7
# ::snt with hairy cell leukemia. In almost every case, the medicine erased
(x13 / erase
	:ARG2 (x4 / disease
		:name (n / name
			:op1 "leukemia")
		:mod (x2 / hairy)
		:mod (x3 / cell))
	:topic (x9 / case
		:mod (x8 / every
			:mod (x7 / almost)))
	:ARG0 (x12 / medicine))

# ::id 8
# ::snt all signs of the disease.
(x2 / sign-01
	:quant (x1 / all)
	:ARG1 (x5 / disease))

# ::id 9
# ::snt 
(x4 / affect-01
	:ARG0 (x3 / disease
		:name (n / name
			:op1 "leukemia")
		:mod (x1 / hairy)
		:ARG1 (x2 / cell))
	:ARG1 (x8 / cell
		:null_edge (x6 / white)
		:mod (x7 / blood)
		:ARG0-of (x10 / make-02)))

# ::id 10
# ::snt disease-fighting antibodies. Doctors are also testing the drug
(x2 / antibody
	:mod (x1 / disease-fighting)
	:ARG0-of (x7 / test-01
		:ARG0 (x4 / doctor)
		:mod (x6 / also)
		:ARG1 (x9 / drug)))

# ::id 11
# ::snt against chronic lymphocytic leukemia, non-Hodgkins lymphoma and
(x8 / and
	:mod (x6 / organization
		:name (n / name
			:op1 "non-Hodgkins"))
	:op1 (x7 / lymphoma
		:ARG1 (x4 / disease
			:name (n1 / name
				:op1 "leukemia")
			:mod (x2 / chronic)
			:mod (x3 / lymphocytic))))

# ::id 12
# ::snt cutaneous T cell lymphoma.
(x4 / lymphoma
	:mod (x1 / cutaneous)
	:ARG1 (x3 / cell))

# ::id 13
# ::snt The Scripps doctors concluded that the medicine, called
(x4 / conclude-01
	:ARG0 (x3 / doctor
		:mod (x2 / scripps))
	:ARG1 (x9 / call-03
		:ARG0 (x7 / medicine)))

# ::id 14
# ::snt 2-chlorodeoxyadenosine, or 2-CdA, "may well be the drug of choice
(x7 / possible
	:domain (x11 / drug
		:domain (x3 / or
			:op1 (x1 / 2-chlorodeoxyadenosine)
			:op2 (x4 / 2-cda))))

# ::id 15
# ::snt in the treatment of hairy cell leukemia."
(x3 / treat-03
	:ARG1 (x7 / disease
		:name (n / name
			:op1 "leukemia")
		:mod (x5 / hairy)
		:mod (x6 / cell)))

# ::id 16
# ::snt The study was directed by Dr. Lawrence D. Piro and published in
(x10 / and
	:op1 (x4 / direct-01
		:ARG1 (x2 / study)
		:ARG2 (x7 / name
			:op1 "Lawrence"
			:op2 "D."
			:op3 "Piro"))
	:op2 (x11 / publish-01))

# ::id 17
# ::snt the New England Journal of Medicine.
(x4 / journal
	:null_edge (x2 / null_tag)
	:poss (x3 / country
		:name (n / name
			:op1 "England"))
	:null_edge (x6 / medicine))

# ::id 18
# ::snt In their study, doctors gave the drug to 12 patients. Of these,
(x6 / give-01
	:ARG0 (x3 / study-01)
	:ARG0 (x5 / doctor)
	:ARG1 (x8 / drug)
	:ARG2 (x11 / patient
		:quant 12
		:ARG1-of (x13 / include-91)))

# ::id 19
# ::snt 11 have remained completely free of all signs of the disease for
(x3 / remain-01
	:ARG1 (x1 / person
		:op 11)
	:ARG3 (x5 / free-01
		:degree (x4 / complete)
		:ARG2 (x8 / sign
			:quant (x7 / all)
			:ARG1 (x11 / disease))))

# ::id 20
# ::snt periods up to four years.
(x1 / period
	:duration (x5 / temporal-quantity
		:unit (y / year)))

# ::id 21
# ::snt The doctors cautioned that longer follow-up will be necessary
(x3 / caution-01
	:ARG0 (x2 / doctor)
	:ARG1 (x6 / follow-up))

# ::id 22
# ::snt before they can be sure they have actually cured the disease.
(x9 / cure-01
	:time (x1 / before
		:op1 (x3 / possible
			:domain (x5 / sure)))
	:mod (x8 / actual)
	:ARG1 (x11 / disease))

# ::id 23
# ::snt Two other treatments for hairy cell leukemia have been developed
(x10 / develop-02
	:ARG1 (x3 / treat-03
		:quant 2
		:mod (x2 / other)
		:purpose (x7 / disease
			:name (n / name
				:op1 "leukemia")
			:mod (x5 / hairy)
			:mod (x6 / cell))))

# ::id 24
# ::snt in recent years. They are interferon and deoxycoformycin, a drug
(x8 / and
	:op1 (x7 / interferon
		:duration (x3 / temporal-quantity
			:unit (y / year)
			:mod (x2 / recent))
		:domain (x5 / they))
	:op2 (x9 / deoxycoformycin))

# ::id 25
# ::snt that is similar to 2-CdA. However, interferon is less effective,
(x3 / resemble-01
	:op (s / similar)
	:ARG1 (x1 / that)
	:ARG2 (x5 / 2-cda)
	:null_edge (x12 / effective
		:domain (x9 / interferon)
		:degree (x11 / less)))

# ::id 26
# ::snt and both of those treatments produce serious side effects.
(x1 / and
	:op1 (x6 / produce-01
		:ARG1 (x5 / treat-03)
		:ARG1 (x9 / effect-01
			:mod (x7 / serious)
			:mod (x8 / side))))

# ::id 27
# ::snt By contrast, the only unwanted effect of 2-CdA was a few days of
(x7 / effect-01
	:beneficiary (x2 / contrast-01)
	:mod (x5 / only)
	:mod (x6 / unwanted)
	:ARG1 (x9 / 2-cda)
	:ARG1 (x12 / few
		:op1 (x13 / temporal-quantity
			:unit (d / day)
			:ARG1-of (x14 / include-91))))

# ::id 28
# ::snt fever. Patients experienced no nausea, hair loss, rashes or other
(x4 / experience-01
	:ARG0 (x3 / patients
		:null_edge (x1 / fever))
	:ARG1 (x12 / or
		:op1 (x6 / nausea
			:polarity -
			:mod (x13 / other))
		:op2 (x9 / loss
			:ARG1 (x8 / hair))
		:op2 (x11 / rash)))

# ::id 29
# ::snt symptoms typical of cancer therapy. Also unlike other treatments,
(x1 / symptom
	:mod (x2 / typify-01
		:domain (x5 / therapy
			:mod (x4 / cancer)
			:ARG3-of (x10 / treat-03
				:mod (x9 / other)))))

# ::id 30
# ::snt this one appears to work after a single seven-day course of therapy.
(x3 / appear-02
	:ARG1 (x2 / one
		:mod (x1 / this))
	:ARG1 (x5 / work-01
		:ARG0 x2
		:time (x6 / after
			:op1 (x10 / course-01
				:ARG1 (x12 / therapy)))))

# ::id 31
# ::snt The Scripps Clinic reached an agreement recently with Johnson &
(x4 / reach-01
	:ARG0 (x3 / clinic
		:mod (x2 / scripps))
	:ARG1 (x6 / agree-01)
	:time (x7 / recent)
	:accompanier (x9 / name
		:op1 "Johnson"
		:op2 "&"))

# ::id 32
# ::snt Johnson's Ortho Pharmaceuticals to produce the drug, which is not
(x6 / produce-01
	:ARG0 (x4 / organization
		:name (n / name
			:op1 "Pharmaceuticals")
		:null_edge (x1 / person
			:name (n1 / name
				:op1 "Johnson"))
		:null_edge (x3 / organization
			:name (n2 / name
				:op1 "Ortho")))
	:ARG1 (x8 / drug))

# ::id 33
# ::snt yet approved for routine use.
(x2 / approve-01
	:ARG1 (x5 / use-01
		:mod (x4 / routine)))

